Plasminogen binds to plasmin-modulated factor Xa by Ca2+- and C-terminal lysine-dependent and -independent interactions

Summary Plasminogen binding to receptors involves both C-terminal lysine-dependent and -independent interactions. The latter are poorly understood. Our earlier work demonstrated a novel Ca2+-enhanced bivalent interaction between plasmin-cleaved FXa (FXa33/13) and plasminogen truncated at Lys78 (Lys-Pg). Here we hypothesized that the effects of Ca2+may enable dissection of the C-terminal lysine-dependent and -independent interactions. To evaluate the role of the Glu-plasminogen (Glu-Pg) amino acids 1–77, binding of FXa33/13 to immobilized Glu-Pg was compared to Lys-Pg by surface plasmon resonance. Under identical conditions, approximately half the amount of FXa33/13 bound to Glu-Pg. The simplest fit of data suggested a 2:1 plasminogen:FXa33/13 stoichiometry for both, which were proportionately enhanced by Ca2+. Only Lys-Pg demonstrated significant Ca2+-independent binding to FXa33/13. In the presence of Ca2+, weak C-terminal lysine-independent binding could be detected, but only for Glu-Pg. The elastase-generated plasminogen fragment encompassing the angiostatin-like kringle domains 1 to 3 (K1–3) inhibited binding of FXa33/13 to Lys-Pg, whereas fragments corresponding to kringle 4- and kringle 5-protease domain had no effect. Immobilized K1–3 binding to FXa33/13 had both Ca2+-dependent and -independent components. The principal KMd for the interaction was 10-fold higher than Lys-Pg. In the presence of Ca2+, eACA inhibited FXa33/13 binding to K1–3 by 30%, but eliminated binding in the absence of Ca2+. These studies suggest that Ca2+-dependent and -independent binding of Lys-Pg to FXa33/13 are C-terminal lysine-dependent. The N-terminal 1–77 amino acids of Glu-Pg confer significant C-terminal lysine-independent binding, which may play a role during the initiating stages of plasminogen activation.

[1]  S. Pizzo,et al.  Angiostatin's molecular mechanism: Aspects of specificity and regulation elucidated , 2005, Journal of cellular biochemistry.

[2]  C. Longstaff,et al.  Understanding the enzymology of fibrinolysis and improving thrombolytic therapy , 2005, FEBS letters.

[3]  K. Hajjar,et al.  Molecular mechanisms of fibrinolysis , 2005, British journal of haematology.

[4]  C R MacKenzie,et al.  Binding of plasminogen and tissue plasminogen activator to plasmin-modulated factor X and factor Xa. , 2001, Biochemistry.

[5]  V. Ellis,et al.  Cellular mechanisms regulating non-haemostatic plasmin generation. , 2001, Biochemical Society transactions.

[6]  S. Moestrup,et al.  The Plasminogen Binding Site of the C-Type Lectin Tetranectin Is Located in the Carbohydrate Recognition Domain, and Binding Is Sensitive to Both Calcium and Lysine* , 1998, The Journal of Biological Chemistry.

[7]  D. Marti,et al.  Kringle 2 Mediates High Affinity Binding of Plasminogen to an Internal Sequence in Streptococcal Surface Protein PAM* , 1998, The Journal of Biological Chemistry.

[8]  A. Tulinsky,et al.  Structure and ligand binding determinants of the recombinant kringle 5 domain of human plasminogen. , 1998, Biochemistry.

[9]  A. Shinomiya,et al.  The Role of Annexin II Tetramer in the Activation of Plasminogen* , 1998, The Journal of Biological Chemistry.

[10]  E. Pryzdial,et al.  Autoproteolysis or Plasmin-mediated Cleavage of Factor Xaα Exposes a Plasminogen Binding Site and Inhibits Coagulation* , 1996, The Journal of Biological Chemistry.

[11]  G. Markus Conformational changes in plasminogen, their effect on activation, and the agents that modulate activation rates — a review , 1996 .

[12]  E. Gabazza,et al.  Characterization of the binding of factor Xa to fibrinogen/fibrin derivatives and localization of the factor Xa binding site on fibrinogen. , 1995, European journal of biochemistry.

[13]  E. Pryzdial,et al.  Prothrombinase Components Can Accelerate Tissue Plasminogen Activator-catalyzed Plasminogen Activation (*) , 1995, The Journal of Biological Chemistry.

[14]  T. Orfeo,et al.  Osteonectin in matrix remodeling. A plasminogen-osteonectin-collagen complex. , 1994, The Journal of biological chemistry.

[15]  K. Hajjar,et al.  An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation. , 1994, The Journal of biological chemistry.

[16]  K. Hajjar,et al.  An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. , 1994, The Journal of biological chemistry.

[17]  P. Hogg,et al.  Effects of Ca2+ binding on the protease module of factor Xa and its interaction with factor Va. Evidence for two Gla-independent Ca(2+)-binding sites in factor Xa. , 1993, Journal of Biological Chemistry.

[18]  M. Nesheim,et al.  Lys-plasminogen is a significant intermediate in the activation of Glu-plasminogen during fibrinolysis in vitro. , 1992, The Journal of biological chemistry.

[19]  P. Ganz,et al.  Identification of an endothelial cell surface protein that binds plasminogen , 1991, Molecular and Cellular Biochemistry.

[20]  R. Karlsson,et al.  Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology. , 1991, BioTechniques.

[21]  Jordi Félez,et al.  Cellular Regulation of Fibrinolysis , 1991, Thrombosis and Haemostasis.

[22]  Jordi Félez,et al.  Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-enolase as a candidate plasminogen receptor. , 1991, Biochemistry.

[23]  G. Larsen,et al.  The dissociation constants and stoichiometries of the interactions of Lys-plasminogen and chloromethyl ketone derivatives of tissue plasminogen activator and the variant delta FEIX with intact fibrin. , 1990, The Journal of biological chemistry.

[24]  K. Hajjar,et al.  Endothelial cell-mediated conversion of Glu-plasminogen to Lys-plasminogen. Further evidence for assembly of the fibrinolytic system on the endothelial cell surface. , 1988, The Journal of clinical investigation.

[25]  D. Waisman,et al.  S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors. , 2005, Frontiers in bioscience : a journal and virtual library.

[26]  F. Castellino,et al.  Critical role for conversion of glu-plasminogen to Lys-plasminogen for optimal stimulation of plasminogen activation on cell surfaces. , 2003, Trends in cardiovascular medicine.

[27]  D.,et al.  Basic and Clinical Aspects of Fibrinolysis and Thrombolysis , 2003 .

[28]  F. Castellino,et al.  The kringle domains of human plasminogen. , 1997, Ciba Foundation symposium.

[29]  Jordi Félez,et al.  Characterization of Cellular Binding Sites and Interactive Regions within Reactants Required for Enhancement of Plasminogen Activation by tPA on the Surface of Leukocytic Cells , 1996, Thrombosis and Haemostasis.

[30]  K. Mann,et al.  Assembly of prothrombinase complex. , 1993, Methods in enzymology.